Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

oncology

A collection of 9 Posts

FDA Approves Regeneron's Libtayo for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma post image
FDA Approvals fda-approval oncology clinical-trials

FDA Approves Regeneron's Libtayo for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

by Newsdesk
FDA Grants Fast Track Designation to Adcendo's ADCE-D01 for Soft Tissue Sarcoma Treatment post image
Regulatory Decisions fda-approval oncology clinical-trials

FDA Grants Fast Track Designation to Adcendo's ADCE-D01 for Soft Tissue Sarcoma Treatment

Featured post
by Newsdesk
Sapu Nano Initiates Phase 1 Clinical Trial for Novel IV Deciparticle™ Everolimus in Oncology post image
Development Milestones clinical-trials oncology drug-development Clinical Trials

Sapu Nano Initiates Phase 1 Clinical Trial for Novel IV Deciparticle™ Everolimus in Oncology

by Newsdesk
Chinese Biotech's Ascent: Novel Cancer Drug Ivonescimab Challenges Global Leaders post image
Breakthrough Research clinical-trials biotech oncology

Chinese Biotech's Ascent: Novel Cancer Drug Ivonescimab Challenges Global Leaders

Featured post
by Newsdesk
PSMA-Targeted Radioligand Therapy Doubles Progression-Free Survival in Recurrent Prostate Cancer, Phase 2 Trial Shows post image
Clinical Trial Results clinical-trials oncology precision-medicine

PSMA-Targeted Radioligand Therapy Doubles Progression-Free Survival in Recurrent Prostate Cancer, Phase 2 Trial Shows

by Newsdesk
UCLA Unveils Key Clinical Trial Outcomes and Imaging Breakthroughs in Radiation Oncology at ASTRO 2025 post image
Clinical Trial Results clinical-trials oncology medical-innovation

UCLA Unveils Key Clinical Trial Outcomes and Imaging Breakthroughs in Radiation Oncology at ASTRO 2025

by Newsdesk
Factor Bioscience Sues AstraZeneca, Cellectis in High-Stakes Gene-Editing Patent Dispute post image
M&A Activity biotech gene-therapy oncology

Factor Bioscience Sues AstraZeneca, Cellectis in High-Stakes Gene-Editing Patent Dispute

by Newsdesk
FDA Fast-Tracks Propel $258B Immunotherapy Market Amidst Breakthrough Oncology Clinical Trials post image
Clinical Trial Results oncology immunotherapy clinical-trials

FDA Fast-Tracks Propel $258B Immunotherapy Market Amidst Breakthrough Oncology Clinical Trials

by Newsdesk
Expedited MRI Protocol Matches Standard for Prostate Cancer Detection in Clinical Trial, Promising Enhanced Accessibility post image
Medical Devices clinical-trials medical-devices oncology

Expedited MRI Protocol Matches Standard for Prostate Cancer Detection in Clinical Trial, Promising Enhanced Accessibility

by Newsdesk